Top compounds associated with response to HLA-G


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.057 0.1
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.058 0.1
mRNA TL-1-85 GDSC1000 pan-cancer AAC -0.052 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA Roscovitine GDSC1000 pan-cancer AAC 0.084 0.1
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.058 0.1
mRNA LE-135 CTRPv2 pan-cancer AAC -0.056 0.1
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.059 0.1
Download CSV